Bill Text: CA SB1292 | 2017-2018 | Regular Session | Enrolled

NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Alzheimer’s disease.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Passed) 2018-09-23 - Chaptered by Secretary of State. Chapter 737, Statutes of 2018. [SB1292 Detail]

Download: California-2017-SB1292-Enrolled.html

Enrolled  September 07, 2018
Passed  IN  Senate  August 31, 2018
Passed  IN  Assembly  August 30, 2018
Amended  IN  Assembly  August 23, 2018
Amended  IN  Senate  May 25, 2018
Amended  IN  Senate  April 02, 2018
Amended  IN  Senate  March 22, 2018

CALIFORNIA LEGISLATURE— 2017–2018 REGULAR SESSION

Senate Bill No. 1292


Introduced by Senator Hueso

February 16, 2018


An act to add and repeal Section 125283 of the Health and Safety Code, relating to Alzheimer’s disease.


LEGISLATIVE COUNSEL'S DIGEST


SB 1292, Hueso. Alzheimer’s disease.
Existing law requires the State Department of Public Health to provide public and professional education on Alzheimer’s disease to educate consumers, caregivers, and health care providers, and to increase public awareness.
This bill would require the Center for Healthy Communities, within the department, on or before January 1, 2021, to update the 2009 Alzheimer’s Disease Facts and Figures in California: Current Status and Future Projections to quantify the burden of Alzheimer’s disease on at-risk and underrepresented populations, including African Americans, Asian-Pacific Islanders, Latinos, Hispanics, and women. The bill would repeal these provisions on January 1, 2025.
Vote: MAJORITY   Appropriation: NO   Fiscal Committee: YES   Local Program: NO  

The people of the State of California do enact as follows:


SECTION 1.

 Section 125283 is added to the Health and Safety Code, to read:

125283.
 (a) The Center for Healthy Communities, within the State Department of Public Health, shall, on or before January 1, 2021, update the 2009 Alzheimer’s Disease Facts and Figures in California: Current Status and Future Projections to quantify the burden of Alzheimer’s disease on at-risk and underrepresented populations, including African Americans, Asian-Pacific Islanders, Latinos, Hispanics, and women.
(b) This section shall remain in effect only until January 1, 2025, and as of that date is repealed.

feedback